Real-World Safety and Effectiveness of Adalimumab in Patients with Juvenile Idiopathic Arthritis: Results from a Post-Marketing Surveillance in Japan

被引：0
|
作者：
Takei, Syuji [1 ]
Iwata, Naomi [2 ]
Kobayashi, Ichiro [3 ,4 ]
Igarashi, Toru [5 ]
Yoshinaga, Yoko [6 ]
Matsubara, Naoko [7 ]
Sunaga, Naomi [8 ]
Ito, Ayumi [7 ]
Yokota, Shumpei [9 ]
机构：
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat, Kagoshima, Japan
[2] Aichi Childrens Hlth & Med Ctr, Dept Immunol & Infect Dis, Obu, Japan
[3] Chiba Childrens Hosp, Dept Allergy & Rheumatol, Sapporo, Hokkaido, Japan
[4] Hokkaido Univ, Sapporo, Hokkaido, Japan
[5] Nippon Med Sch, Tokyo, Japan
[6] AbbVie GK, Med Commun, Med, Evidence Solut, Tokyo, Japan
[7] AbbVie GK, Med, Tokyo, Japan
[8] AbbVie GK, Tokyo, Japan
[9] Fuji Toranomon Orthoped Hosp, Gotemba, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2382
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study
    Takei, Syuji
    Iwata, Naomi
    Kobayashi, Ichiro
    Igarashi, Toru
    Yoshinaga, Yoko
    Matsubara, Naoko
    Sunaga, Naomi
    Ito, Ayumi
    Yokota, Shumpei
    [J]. MODERN RHEUMATOLOGY, 2021, 31 (02) : 421 - 430
  • [2] Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan
    Hayashi, Nobukazu
    Hayama, Koremasa
    Takahashi, Kenzo
    Kurokawa, Ichiro
    Okazaki, Masateru
    Kashiwagi, Tomoko
    Iwashita, Eri
    Terui, Tadashi
    [J]. JOURNAL OF DERMATOLOGY, 2022, 49 (04): : 411 - 421
  • [3] Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database
    Wataya, Takafumi
    Takasaki, Sakura
    Hoshino, Misuzu
    Makioka, Haruki
    Nakamura, Genshu
    Matsuda, Naoto
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (08) : 851 - 863
  • [4] The real-world use of istradefylline for Parkinsons disease: Post-marketing surveillance of safety and effectiveness in Japan
    Takahashi, Makio
    Itou, Satoru
    Horiguchi, Shuji
    Tsuji, Yukie
    [J]. NEUROLOGY, 2022, 98 (18)
  • [5] Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
    Takashi Ogura
    Yoshikazu Inoue
    Arata Azuma
    Sakae Homma
    Yasuhiro Kondoh
    Katsumi Tanaka
    Kaori Ochiai
    Yukihiko Sugiyama
    Toshihiro Nukiwa
    [J]. Advances in Therapy, 2023, 40 (4) : 1474 - 1493
  • [6] Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
    Ogura, Takashi
    Inoue, Yoshikazu
    Azuma, Arata
    Homma, Sakae
    Kondoh, Yasuhiro
    Tanaka, Katsumi
    Ochiai, Kaori
    Sugiyama, Yukihiko
    Nukiwa, Toshihiro
    [J]. ADVANCES IN THERAPY, 2023, 40 (04) : 1474 - 1493
  • [7] Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance
    Hirotsugu Uemura
    Yoshihiko Tomita
    Norio Nonomura
    Kenji Yoshizaki
    Takafumi Nakao
    Nobuo Shinohara
    [J]. International Journal of Clinical Oncology, 2022, 27 : 1061 - 1067
  • [8] Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance
    Uemura, Hirotsugu
    Tomita, Yoshihiko
    Nonomura, Norio
    Yoshizaki, Kenji
    Nakao, Takafumi
    Shinohara, Nobuo
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (06) : 1061 - 1067
  • [9] Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan
    Takayama, Koichi
    Kojima, Ai
    Honda, Chikara
    Nakayama, Masahiro
    Kanemata, Satomi
    Endo, Toshimitsu
    Muro, Kei
    [J]. CANCER MEDICINE, 2024, 13 (09):
  • [10] A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan
    Yamazaki, N.
    Kiyohara, Y.
    Sato, M.
    Endo, S.
    Song, B.
    Tanaka, Y.
    Kambe, A.
    Sato, Y.
    Uhara, H.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S1601 - S1602
12345